<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/india-positions-global-diabetes-rd-hub-glp1-microbiome-therapies</loc>
    <lastmod>2026-11-22T23:54:19+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T00:00:00+05:30</news:publication_date>
      <news:title>India Positions Itself as Global Diabetes R&amp;D Hub Targeting GLP-1 and Microbiome Therapies</news:title>
      <news:keywords>India's</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e033560a-b79d-4586-8319-dc4d9417934f/239fe97a-bc5c-4bee-b500-9421fa1a62bc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/capricor-therapeutics-fda-complete-response-letter-deramiocel-bla-duchenne-muscular-dystrophy</loc>
    <lastmod>2026-11-22T23:51:12+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T00:00:00+05:30</news:publication_date>
      <news:title>Capricor Therapeutics Receives FDA Complete Response Letter for Deramiocel</news:title>
      <news:keywords>Capricor</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2ca7f736-91e0-46d2-b40e-5e797e0c4ed8/bd74b135-4567-4729-ab1a-99cac5d4c4f1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/greenwich-rx-recalls-compounded-sterile-products-sterility-assurance-fda-inspection-2026</loc>
    <lastmod>2026-11-22T23:49:20+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T00:00:00+05:30</news:publication_date>
      <news:title>Greenwich Rx Recalls Compounded Sterile Products Nationwide</news:title>
      <news:keywords>Greenwich</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bbbe6b51-f712-47b3-af01-bc4c7034d1cf/c8676aeb-ea94-4a8d-92b6-26e047ce36f7.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/breckenridge-pharmaceutical-recalls-propranolol-60mg-metal-contamination-adare-pharma</loc>
    <lastmod>2026-11-22T23:45:27+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T00:00:00+05:30</news:publication_date>
      <news:title>Breckenridge Pharmaceutical Recalls One Lot of Propranolol Capsules</news:title>
      <news:keywords>Breckenridge</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bbbe6b51-f712-47b3-af01-bc4c7034d1cf/3d4bfb19-5727-49f2-9ea2-aeeec65dd6fc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-cber-rejects-stephen-j-fallon-capa-response-bars-future-clinical-trials</loc>
    <lastmod>2026-11-22T23:42:10+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T00:00:00+05:30</news:publication_date>
      <news:title>FDA CBER Rejects Stephen J. Fallon's CAPA Response, Bars Future Clinical Trial Participation</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bbbe6b51-f712-47b3-af01-bc4c7034d1cf/891c481b-a926-43a8-8a93-091141b2f09e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/capricor-crl-deramiocel-bla-hope-3-data-integrity-fda</loc>
    <lastmod>2026-11-22T23:40:34+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T00:00:00+05:30</news:publication_date>
      <news:title>Capricor Receives CRL for Deramiocel BLA After FDA Cites Irreparable Data Integrity Violations in HOPE-3</news:title>
      <news:keywords>Capricor</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bbbe6b51-f712-47b3-af01-bc4c7034d1cf/0a7ddd0a-c9a2-4ee8-a32d-05e3a13581ff.png</image:loc>
    </image:image>
  </url>
</urlset>